Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Socrates E Papapoulos

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Annals of the New York Academy of Sciences|October 16, 2010
Use of bisphosphonates in the management of postmenopausal osteoporosisSocrates E Papapoulos
Best Practice & Research. Clinical Endocrinology & Metabolism|November 26, 2008
Bisphosphonates: how do they work?Socrates E Papapoulos
Annals of the Rheumatic Diseases|February 23, 2011
Targeting sclerostin as potential treatment of osteoporosisSocrates E Papapoulos
Best Practice & Research. Clinical Rheumatology|November 23, 2005
Who will benefit from antiresorptive treatment (bisphosphonates)?Socrates E Papapoulos
Hormone Research in Paediatrics|July 23, 2011
Bisphosphonate therapy in children with secondary osteoporosisSocrates E Papapoulos
Bone|January 21, 2020
Pamidronate: A model compound of the pharmacology of nitrogen-containing bisphosphonates; A Leiden historical perspectiveSocrates E Papapoulos
Hormones (Athens, Greece)|July 3, 2009
Medical treatment of hypercalcaemiaPolyzois Makras, Socrates E Papapoulos
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the FutureSocrates E Papapoulos, Polyzois Makras
Expert Review of Endocrinology & Metabolism|February 16, 2019
Targeting the Wnt signaling pathway for the development of novel therapies for osteoporosisMaria P Yavropoulou, Socrates E Papapoulos
Drugs|June 10, 2015
Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal OsteoporosisNatasha M Appelman-Dijkstra, Socrates E Papapoulos
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Annals of the New York Academy of Sciences|October 16, 2010
Use of bisphosphonates in the management of postmenopausal osteoporosisSocrates E Papapoulos
Best Practice & Research. Clinical Endocrinology & Metabolism|November 26, 2008
Bisphosphonates: how do they work?Socrates E Papapoulos
Annals of the Rheumatic Diseases|February 23, 2011
Targeting sclerostin as potential treatment of osteoporosisSocrates E Papapoulos
Best Practice & Research. Clinical Rheumatology|November 23, 2005
Who will benefit from antiresorptive treatment (bisphosphonates)?Socrates E Papapoulos
Hormone Research in Paediatrics|July 23, 2011
Bisphosphonate therapy in children with secondary osteoporosisSocrates E Papapoulos
Bone|January 21, 2020
Pamidronate: A model compound of the pharmacology of nitrogen-containing bisphosphonates; A Leiden historical perspectiveSocrates E Papapoulos
Hormones (Athens, Greece)|July 3, 2009
Medical treatment of hypercalcaemiaPolyzois Makras, Socrates E Papapoulos
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the FutureSocrates E Papapoulos, Polyzois Makras
Expert Review of Endocrinology & Metabolism|February 16, 2019
Targeting the Wnt signaling pathway for the development of novel therapies for osteoporosisMaria P Yavropoulou, Socrates E Papapoulos
Drugs|June 10, 2015
Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal OsteoporosisNatasha M Appelman-Dijkstra, Socrates E Papapoulos
Pageof 8